Multi-Walled Carbon Nanotubes Effective in Levofloxacine Drug Delivery

Carbon nanotubes (CNTs) are promising nano-carriers in biomedical applications. In an article recently published in the journal Scientific Reports, the researchers reported a nano-antibiotic by conjugating levofloxacin with multi-walled CNTs (MWCNT-LVX), wherein the drug was grafted with surface-modified CNT to achieve a nano-drug that is safe, effective, and fast-acting.

Multi-Walled Carbon Nanotubes Effective in Levofloxacine Drug Delivery​​​​​​​

​​​​​​​Study: Robust antibacterial activity of functionalized carbon nanotube- levofloxacine conjugate based on in vitro and in vivo studies. Image Credit: Hassani, M., et al (2022)

Nanomaterials as Antibacterial Drug Delivery Systems

Enhancing the antibacterial agent’s efficacy by employing combination therapy or drug delivery systems based on nanotechnology can expedite the drug development process. Recently, nanomaterials have been extensively applied as nano-carriers for antibacterial drug delivery, especially to treat resistant infections.

The high surface area to volume ratios, hollow structure, ideal compatibility, and remarkable penetration through cell membrane are a few favorable properties of CNTs for their application as nano-carriers. Nevertheless, the poor dispersibility, toxicity, and hydrophobic nature of MWCNTs limit their biomedical applications. To this end, surface modification of MWCNTs using various functionalization approaches can enhance their dispersity and biocompatibility under physiological conditions.

MWCNT-LVX

In the present study, the researchers synthesized a new nano-antibiotic, MWCNT-LVX, by grafting the drug covalently with surface-modified CNTs to achieve a safe, effective, and fast-acting nano-drug. They employed an ultraviolet-visible (UV-vis) spectrometer to evaluate the drug-loading and release profiles at different pH levels.

The synthesized MWCNT-LVX was characterized using a scanning electron microscope (SEM), transmission electron microscope (TEM), and Brunauer–Emmett–Teller analysis. The nano-antibiotic showed better in vitro antibacterial activity against Staphylococcus aureus than Pseudomonas aeruginosa.

The novel nano-drug exhibited high drug loading capacity and pH-sensitive release profile, thus exhibiting more potent bactericidal activity against Staphylococcus aureus infection in mouse model than pure LVX. Based on the obtained results, the researchers revealed that the conjugation of the drug with surface-modified MWCNTs enhanced the antibacterial properties of the drug.

Thus nano-antibiotics have great potential for industrialization for their nontoxicity, proper drug loading and release, simple synthetic route, and strong antimicrobial activity. Moreover, owing to their unique physicochemical properties, MWCNTs can serve as good drug delivery systems with controlled release ability. Their ease of penetration through biological membranes can enhance the drug delivery even at low doses, which further helps in reducing the side effects.

Research Findings

The Fourier transform infrared (FTIR) spectra of MWCNT-COOH showed a strong peak at 1629-centimeter inverse, corresponding to stretching vibrations of carbonyl (C=O), whose presence also confirms the oxidation of CNTs. The IR bands at 1695 and 779-centimeter inverse corroborated the stretching vibrations of MWCNT-acyl chloride (COCl), confirming the successful chlorination of MWCNT-COOH. Further, the amidation reaction on MWCNT-COCl showed the carbonyl stretching vibrations in the MWCNT-NH2 at 1625 and 1679-centimeter inverse, confirming the elimination of the acyl chloride group.

In the present study, the pH-controlled delivery of LVX was possible using MWCNT-LVX at pH values of 5.5, 7.4, and 10.5. They observed that at pH 5.5 complete and sustained release of the drug was achieved by MWCNT-LVX by day five. Approximately 25 to 50% of LVX was released between 6 and 24 hours in acid media. At pH 7.4, the LVX release was in a slow and controlled manner after day four.

LVX was attached to the surface-modified MWCNTs via hydrogen bonds, which were weakened at a pH of 5.5, triggering the release of LVX at a higher amount. Moreover, the amide bonds that existed between LVX and MWCNT-NH2 were steadily hydrolyzed in acidic media, which indicates the drug was released over an extended period.

The above results confirm that a single dose of MWCNTLVX can maintain a high local LVX concentration for several days, avoiding the need to administer multiple doses and the consequent side effects. The common agglomeration problem in CNTs was overcome by the surface modification of MWCNTs, leading to easy dispersion in biological media.

The field emission SEM images showed the nano-antibiotic’s groovy and rough surface; this uneven surface was due to the distribution of the drug in MWCNT’s surface via covalent and non-covalent attachments. Moreover, TEM analyses with high magnification confirmed the dispersion of MWNTs. TEM images revealed the interlocking of MWCNT-COOH with each other. However, a layer of the drug was observed after loading the MWCNT-NH2 with the respective drug.

Conclusion

In conclusion, the researchers successfully synthesized an antibacterial nano-conjugate by covalently grafting the drug on surface-modified MWCNTs. The biocompatibility and aqueous dispersity of the synthesized nano-antibiotic was enhanced by the amino-polyethyleneglycol (PEG)2-amine (NH2) linker that existed between the drug and MWCNTs. The observation drawn on the high drug loading capacity of MWCNTs and the pH-sensitive release of the drug affirmed the efficiency of MWCNT-NH2.

The topical administration of the nano-antibiotics solution confirmed the potent antibacterial activity on Staphylococcus aureus-infected burn wounds. Further, the as-prepared new nano-antibiotic enhanced the biocompatibility without exhibiting toxicity, which confirms its efficacy in treating the infection caused by Staphylococcus aureus.

Reference

Hassani, M., Tahghighi, A., Rohani, M., Hekmati, M., Ahmadian, M., & Ahmadvand, H. (2022). Robust antibacterial activity of functionalized carbon nanotube-levofloxacine conjugate based on in vitro and in vivo studies. Scientific Reports. https://www.nature.com/articles/s41598-022-14206-w

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Bhavna Kaveti

Written by

Bhavna Kaveti

Bhavna Kaveti is a science writer based in Hyderabad, India. She has a Masters in Pharmaceutical Chemistry from Vellore Institute of Technology, India, and a Ph.D. in Organic and Medicinal Chemistry from Universidad de Guanajuato, Mexico. Her research work involved designing and synthesizing heterocycle-based bioactive molecules, where she had exposure to both multistep and multicomponent synthesis. During her doctoral studies, she worked on synthesizing various linked and fused heterocycle-based peptidomimetic molecules that are anticipated to have a bioactive potential for further functionalization. While working on her thesis and research papers, she explored her passion for scientific writing and communications.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kaveti, Bhavna. (2022, June 21). Multi-Walled Carbon Nanotubes Effective in Levofloxacine Drug Delivery. AZoNano. Retrieved on July 02, 2022 from https://www.azonano.com/news.aspx?newsID=39303.

  • MLA

    Kaveti, Bhavna. "Multi-Walled Carbon Nanotubes Effective in Levofloxacine Drug Delivery". AZoNano. 02 July 2022. <https://www.azonano.com/news.aspx?newsID=39303>.

  • Chicago

    Kaveti, Bhavna. "Multi-Walled Carbon Nanotubes Effective in Levofloxacine Drug Delivery". AZoNano. https://www.azonano.com/news.aspx?newsID=39303. (accessed July 02, 2022).

  • Harvard

    Kaveti, Bhavna. 2022. Multi-Walled Carbon Nanotubes Effective in Levofloxacine Drug Delivery. AZoNano, viewed 02 July 2022, https://www.azonano.com/news.aspx?newsID=39303.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit